These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 27992920)
1. In type 1 diabetes, adding liraglutide to insulin increased hypoglycemia and hyperglycemia with ketosis. Tanner M Ann Intern Med; 2016 Dec; 165(12):JC64. PubMed ID: 27992920 [No Abstract] [Full Text] [Related]
2. Adjuvant Liraglutide and Insulin Versus Insulin Monotherapy in the Closed-Loop System in Type 1 Diabetes: A Randomized Open-Labeled Crossover Design Trial. Ilkowitz JT; Katikaneni R; Cantwell M; Ramchandani N; Heptulla RA J Diabetes Sci Technol; 2016 Sep; 10(5):1108-14. PubMed ID: 27184690 [TBL] [Abstract][Full Text] [Related]
3. First fixed-ratio combination of insulin degludec and liraglutide for the treatment of type 2 diabetes. Rendell M Drugs Today (Barc); 2015 Mar; 51(3):185-96. PubMed ID: 25876562 [TBL] [Abstract][Full Text] [Related]
4. Evidence That in Uncontrolled Diabetes, Hyperglucagonemia Is Required for Ketosis but Not for Increased Hepatic Glucose Production or Hyperglycemia. Meek TH; Dorfman MD; Matsen ME; Fischer JD; Cubelo A; Kumar MR; Taborsky GJ; Morton GJ Diabetes; 2015 Jul; 64(7):2376-87. PubMed ID: 25633417 [TBL] [Abstract][Full Text] [Related]
5. Fixed combination of insulin and a glucagon-like peptide-1 analog for the treatment of type 2 diabetes, exemplified by insulin degludec and liraglutide. Vedtofte L; Knop FK; Vilsbøll T Expert Rev Clin Pharmacol; 2015 May; 8(3):273-82. PubMed ID: 25816888 [TBL] [Abstract][Full Text] [Related]
6. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. Ly TT; Nicholas JA; Retterath A; Lim EM; Davis EA; Jones TW JAMA; 2013 Sep; 310(12):1240-7. PubMed ID: 24065010 [TBL] [Abstract][Full Text] [Related]
8. Liraglutide improves cardiac function in patients with type 2 diabetes and chronic heart failure. Arturi F; Succurro E; Miceli S; Cloro C; Ruffo M; Maio R; Perticone M; Sesti G; Perticone F Endocrine; 2017 Sep; 57(3):464-473. PubMed ID: 27830456 [TBL] [Abstract][Full Text] [Related]
9. Twelve-Week Treatment With Liraglutide as Add-on to Insulin in Normal-Weight Patients With Poorly Controlled Type 1 Diabetes: A Randomized, Placebo-Controlled, Double-Blind Parallel Study. Frandsen CS; Dejgaard TF; Holst JJ; Andersen HU; Thorsteinsson B; Madsbad S Diabetes Care; 2015 Dec; 38(12):2250-7. PubMed ID: 26486191 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological efficacy of FGF21 analogue, liraglutide and insulin glargine in treatment of type 2 diabetes. Ye X; Qi J; Yu D; Wu Y; Zhu S; Li S; Wu Q; Ren G; Li D J Diabetes Complications; 2017 Apr; 31(4):726-734. PubMed ID: 28143735 [TBL] [Abstract][Full Text] [Related]
11. Liraglutide and the preservation of pancreatic β-cell function in early type 2 diabetes: the LIBRA trial. Retnakaran R; Kramer CK; Choi H; Swaminathan B; Zinman B Diabetes Care; 2014 Dec; 37(12):3270-8. PubMed ID: 25249651 [TBL] [Abstract][Full Text] [Related]
12. Liraglutide Improves Glycemic and Blood Pressure Control and Ameliorates Progression of Left Ventricular Hypertrophy in Patients with Type 2 Diabetes Mellitus on Peritoneal Dialysis. Hiramatsu T; Ozeki A; Asai K; Saka M; Hobo A; Furuta S Ther Apher Dial; 2015 Dec; 19(6):598-605. PubMed ID: 26556397 [TBL] [Abstract][Full Text] [Related]
14. Attitude, complications, ability of fasting and glycemic control in fasting Ramadan by children and adolescents with type 1 diabetes mellitus. Deeb A; Al Qahtani N; Akle M; Singh H; Assadi R; Attia S; Al Suwaidi H; Hussain T; Naglekerke N Diabetes Res Clin Pract; 2017 Apr; 126():10-15. PubMed ID: 28189949 [TBL] [Abstract][Full Text] [Related]
15. Sick Day Management in Children and Adolescents with Type 1 Diabetes. Choudhary A J Ark Med Soc; 2016 Jun; 112(14):284-6. PubMed ID: 27434984 [TBL] [Abstract][Full Text] [Related]
16. Contribution of liraglutide in the fixed-ratio combination of insulin degludec and liraglutide (IDegLira). Buse JB; Vilsbøll T; Thurman J; Blevins TC; Langbakke IH; Bøttcher SG; Rodbard HW; Diabetes Care; 2014 Nov; 37(11):2926-33. PubMed ID: 25114296 [TBL] [Abstract][Full Text] [Related]
17. Neurturin and a GLP-1 Analogue Act Synergistically to Alleviate Diabetes in Zucker Diabetic Fatty Rats. Trevaskis JL; Sacramento CB; Jouihan H; Ali S; Le Lay J; Oldham S; Bhagroo N; Boland BB; Cann J; Chang Y; O'Day T; Howard V; Reers C; Winzell MS; Smith DM; Feigh M; Barkholt P; Schreiter K; Austen M; Andag U; Thompson S; Jermutus L; Coghlan MP; Grimsby J; Dohrmann C; Rhodes CJ; Rondinone CM; Sharma A Diabetes; 2017 Jul; 66(7):2007-2018. PubMed ID: 28408435 [TBL] [Abstract][Full Text] [Related]
18. Liraglutide for treating type 1 diabetes. Dejgaard TF; Frandsen CS; Holst JJ; Madsbad S Expert Opin Biol Ther; 2016; 16(4):579-90. PubMed ID: 26926662 [TBL] [Abstract][Full Text] [Related]
19. Effects of performing morning versus afternoon exercise on glycemic control and hypoglycemia frequency in type 1 diabetes patients on sensor-augmented insulin pump therapy. Gomez AM; Gomez C; Aschner P; Veloza A; Muñoz O; Rubio C; Vallejo S J Diabetes Sci Technol; 2015 May; 9(3):619-24. PubMed ID: 25555390 [TBL] [Abstract][Full Text] [Related]
20. Type 1 diabetes treatment beyond insulin: role of GLP-1 analogs. Harrison LB; Mora PF; Clark GO; Lingvay I J Investig Med; 2013 Jan; 61(1):40-4. PubMed ID: 23222002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]